# SMG6

## Overview
SMG6 is a gene that encodes the SMG6 nonsense-mediated mRNA decay factor, a protein integral to the nonsense-mediated mRNA decay (NMD) pathway. This pathway is a crucial cellular mechanism that identifies and degrades mRNAs containing premature termination codons, thereby preventing the synthesis of potentially deleterious truncated proteins. The SMG6 protein is characterized by its C-terminal PilT N-terminus (PIN) domain, which functions as an endonuclease, and a 14-3-3-like domain that facilitates interactions with phosphorylated UPF1, a key NMD factor (Glavan2006Structures; Chakrabarti2014Phosphodependent). Beyond its role in mRNA surveillance, SMG6 is also involved in telomere maintenance through interactions with telomerase components (Redon2007Protein–RNA). Alterations in SMG6 expression have been linked to various diseases, including cancer and neurological disorders, highlighting its clinical significance (Suzuki2022SMG6; Tao2018SRRintronic).

## Structure
The SMG6 protein is characterized by several distinct domains that contribute to its function in nonsense-mediated mRNA decay (NMD). It contains a C-terminal PIN domain, which exhibits endonuclease activity crucial for mRNA degradation. This domain is structurally similar to T4 RNase H and features a conserved active site with three aspartic acid residues essential for its catalytic function (Glavan2006Structures). The PIN domain is capable of degrading single-stranded RNA in the presence of manganese, highlighting its role in the NMD pathway (Glavan2006Structures).

SMG6 also includes a 14-3-3-like domain, which is involved in interactions with phosphorylated UPF1, a key factor in NMD. This domain is monomeric and does not form dimers like SMG5 and SMG7, due to differences in surface residues that prevent such associations (Chakrabarti2014Phosphodependent). The 14-3-3-like domain is connected to the PIN domain by a low-complexity linker region, which is not essential for NMD function (Huntzinger2008SMG6).

The N-terminal region of SMG6 contains two conserved exon junction complex (EJC)-binding motifs, which are crucial for its recruitment to mRNA targets (Kashima2010SMG6). These structural features and domain interactions underscore SMG6's role in mRNA surveillance and decay.

## Function
SMG6 is a critical component of the nonsense-mediated mRNA decay (NMD) pathway, a quality control mechanism that degrades mRNAs containing premature termination codons (PTCs) to prevent the production of truncated and potentially harmful proteins. In human cells, SMG6 functions as an endonuclease, cleaving mRNA near the PTC, which is essential for initiating mRNA degradation (Nicholson2014A; Huntzinger2008SMG6). The catalytic activity of SMG6 is attributed to its C-terminal PilT N-terminus (PIN) domain, which exhibits nuclease activity on single-stranded RNA (Glavan2006Structures).

SMG6 is recruited to nonsense mRNAs through interactions with phosphorylated UPF1, a key NMD factor, although it also interacts with UPF1 in a phosphorylation-independent manner, which is crucial for its function (Nicholson2014A; Boehm2021SMG5-SMG7). This interaction is necessary for the degradation of mRNA by tethered SMG6, suggesting it plays a role in regulating the enzymatic activities of UPF1 and SMG6 (Nicholson2014A).

SMG6's activity is tightly regulated to prevent unintended degradation of normal mRNAs, with proteins like SMG5 and SMG7 facilitating its proper activation (Boehm2021SMG5-SMG7). This regulation ensures that only faulty mRNAs are targeted for degradation, maintaining cellular homeostasis and influencing gene expression (Schmidt2014Identification).

## Clinical Significance
Alterations in the expression of the SMG6 gene have been implicated in various diseases, particularly in cancer and neurological disorders. In malignant mesothelioma (MM), SMG6 expression is upregulated in LATS2-inactivated cells, a condition that contributes to cell survival and DNA damage repair. Silencing SMG6 in these cells induces apoptosis, suggesting that SMG6 is crucial for the survival of LATS2-inactive cells. This indicates that SMG6 could be a potential therapeutic target for LATS2-mutated cancers such as MM (Suzuki2022SMG6).

In the context of temporal lobe epilepsy (TLE), intronic variations in the SRR gene, which affect the expression of the neighboring SMG6 gene, have been studied. The GG genotype at the rs4523957 SNP in the SRR gene is associated with reduced SMG6 expression and a protective effect against TLE. This suggests that decreased SMG6 expression may reduce susceptibility to epileptic seizures, highlighting a potential protective role of SMG6 downregulation in TLE (Tao2018SRRintronic).

These findings underscore the clinical significance of SMG6 in both cancer and neurological disorders, where its expression levels and interactions play critical roles in disease progression and potential therapeutic interventions.

## Interactions
SMG6, a key player in the nonsense-mediated mRNA decay (NMD) pathway, engages in several critical interactions with proteins and nucleic acids. It interacts with the phosphorylated UPF1 protein, a central component of the NMD pathway, through its 14-3-3-like domain. This interaction is essential for the recruitment of SMG6 to mRNAs containing premature termination codons (PTCs) (Huntzinger2008SMG6; Schmidt2014Identification). SMG6 also forms complexes with SMG5 and SMG7, which are necessary for its endonucleolytic activity. The presence of SMG5-SMG7 facilitates the activation of SMG6, allowing it to cleave mRNA substrates (Boehm2021SMG5-SMG7).

In addition to its role in NMD, SMG6, also known as hEST1A, interacts with telomerase components. It binds to the telomerase RNA component (hTR) and the telomerase reverse transcriptase (hTERT) through both RNA-dependent and RNA-independent interactions. These interactions suggest a role for SMG6 in telomere maintenance and regulation (Redon2007Protein–RNA). These multifaceted interactions highlight SMG6's involvement in both mRNA surveillance and telomere biology.


## References


[1. (Tao2018SRRintronic) Hua Tao, Xu Zhou, Qian Xie, Zhonghua Ma, Fuhai Sun, Lili Cui, Yujie Cai, Guoda Ma, Jiawu Fu, Zhou Liu, You Li, Haihong Zhou, Jianghao Zhao, Yanyan Chen, Hui Mai, Ying Chen, Jun Chen, Wei Qi, Chaowen Sun, Bin Zhao, and Keshen Li. <scp>srr</scp>intronic variation inhibits expression of its neighbouring<scp>smg</scp>6 gene and protects against temporal lobe epilepsy. Journal of Cellular and Molecular Medicine, 22(3):1883–1893, January 2018. URL: http://dx.doi.org/10.1111/jcmm.13473, doi:10.1111/jcmm.13473. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1111/jcmm.13473)

[2. (Huntzinger2008SMG6) Eric Huntzinger, Isao Kashima, Maria Fauser, Jérôme Saulière, and Elisa Izaurralde. Smg6 is the catalytic endonuclease that cleaves mrnas containing nonsense codons in metazoan. RNA, 14(12):2609–2617, October 2008. URL: http://dx.doi.org/10.1261/rna.1386208, doi:10.1261/rna.1386208. This article has 267 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1261/rna.1386208)

[3. (Chakrabarti2014Phosphodependent) Sutapa Chakrabarti, Fabien Bonneau, Steffen Schüssler, Elfriede Eppinger, and Elena Conti. Phospho-dependent and phospho-independent interactions of the helicase upf1 with the nmd factors smg5–smg7 and smg6. Nucleic Acids Research, 42(14):9447–9460, July 2014. URL: http://dx.doi.org/10.1093/nar/gku578, doi:10.1093/nar/gku578. This article has 95 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gku578)

[4. (Nicholson2014A) Pamela Nicholson, Christoph Josi, Hitomi Kurosawa, Akio Yamashita, and Oliver Mühlemann. A novel phosphorylation-independent interaction between smg6 and upf1 is essential for human nmd. Nucleic Acids Research, 42(14):9217–9235, July 2014. URL: http://dx.doi.org/10.1093/nar/gku645, doi:10.1093/nar/gku645. This article has 79 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gku645)

[5. (Suzuki2022SMG6) Koya Suzuki, Masaki Tange, Ryota Yamagishi, Hiroyuki Hanada, Satomi Mukai, Tatsuhiro Sato, Takeshi Tanaka, Tomohiro Akashi, Kenji Kadomatsu, Tohru Maeda, Takashi Miida, Ichiro Takeuchi, Hiroshi Murakami, Yoshitaka Sekido, and Yuko Murakami-Tonami. Smg6 regulates dna damage and cell survival in hippo pathway kinase lats2-inactivated malignant mesothelioma. Cell Death Discovery, November 2022. URL: http://dx.doi.org/10.1038/s41420-022-01232-w, doi:10.1038/s41420-022-01232-w. This article has 4 citations and is from a peer-reviewed journal.](https://doi.org/10.1038/s41420-022-01232-w)

[6. (Redon2007Protein–RNA) Sophie Redon, Patrick Reichenbach, and Joachim Lingner. Protein–rna and protein–protein interactions mediate association of human est1a/smg6 with telomerase. Nucleic Acids Research, 35(20):7011–7022, October 2007. URL: http://dx.doi.org/10.1093/nar/gkm724, doi:10.1093/nar/gkm724. This article has 47 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gkm724)

[7. (Boehm2021SMG5-SMG7) Volker Boehm, Sabrina Kueckelmann, Jennifer V. Gerbracht, Sebastian Kallabis, Thiago Britto-Borges, Janine Altmüller, Marcus Krüger, Christoph Dieterich, and Niels H. Gehring. Smg5-smg7 authorize nonsense-mediated mrna decay by enabling smg6 endonucleolytic activity. Nature Communications, June 2021. URL: http://dx.doi.org/10.1038/s41467-021-24046-3, doi:10.1038/s41467-021-24046-3. This article has 61 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1038/s41467-021-24046-3)

[8. (Schmidt2014Identification) Skye A. Schmidt, Patricia L. Foley, Dong-Hoon Jeong, Linda A. Rymarquis, Francis Doyle, Scott A. Tenenbaum, Joel G. Belasco, and Pamela J. Green. Identification of smg6 cleavage sites and a preferred rna cleavage motif by global analysis of endogenous nmd targets in human cells. Nucleic Acids Research, 43(1):309–323, November 2014. URL: http://dx.doi.org/10.1093/nar/gku1258, doi:10.1093/nar/gku1258. This article has 86 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1093/nar/gku1258)

[9. (Kashima2010SMG6) Isao Kashima, Stefanie Jonas, Uma Jayachandran, Gretel Buchwald, Elena Conti, Andrei N. Lupas, and Elisa Izaurralde. Smg6 interacts with the exon junction complex via two conserved ejc-binding motifs (ebms) required for nonsense-mediated mrna decay. Genes &amp; Development, 24(21):2440–2450, October 2010. URL: http://dx.doi.org/10.1101/gad.604610, doi:10.1101/gad.604610. This article has 65 citations.](https://doi.org/10.1101/gad.604610)

[10. (Glavan2006Structures) Filip Glavan, Isabelle Behm-Ansmant, Elisa Izaurralde, and Elena Conti. Structures of the pin domains of smg6 and smg5 reveal a nuclease within the mrna surveillance complex. The EMBO Journal, 25(21):5117–5125, October 2006. URL: http://dx.doi.org/10.1038/sj.emboj.7601377, doi:10.1038/sj.emboj.7601377. This article has 161 citations.](https://doi.org/10.1038/sj.emboj.7601377)